Table 2.
Demographic data and some of the clinical parameters of subjects tested 300 days after the onset of COVID-19 infection.
| COVID-19 Group (N = 49) |
Control Group (N = 50) |
||
|---|---|---|---|
| Gender | M | 25 (51%) * | 25 (50%) |
| F | 24 (49%) * | 25 (50%) | |
| Diabetes melitus | 5 (10%) | 4 (8%) | |
| Arterial hypertension | 7 (14%) | 8 (16%) | |
| Hyperlipidemia | 4 (8%) | 5 (10%) | |
| Alcohol consumption | 0 (0%) | 0 (0%) | |
| Smoking | 3 (6%) | 3 (6%) | |
| Age (years) | 47 ± 6 ** | 48 ± 5 ** | |
| BMI (kg/m2) | 26 ± 3.3 ** | 26 ± 3.2 ** | |
| SBP(mmHg) | 125 ± 12 ** | 124 ± 10 ** | |
| DBP (mmHg) | 77 ± 9.6 ** | 76 ± 9.1 ** | |
Legend: M—male, F—female, BMI—body mass index, SBP—systolic blood pressure, DBP—diastolic blood pressure. * χ2 test; ** t-test.